Showing results (71-80 of 100) with videos related to
Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|November 18, 2024
Mechanistic insights into structure-based design of a Lyme disease subunit vaccineKalvis Brangulis, Jill Malfetano, Ashley L Marcinkiewicz, et al.NPJ Vaccines|May 16, 2026
Developing a durable, memory-driven, CspZ-targeting Lyme disease vaccine by rationale adjuvant selectionMiranda McCarty, Sergio A Hernández, Jill Malfetano, et al.Vaccine|March 3, 2018
Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigenMun Peak Nyon, Lanying Du, Chien-Te Kent Tseng, et al.ACS Applied Materials & Interfaces|March 22, 2024
Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas DiseaseChiara Mancino, Jeroen Pollet, Assaf Zinger, et al.Journal of Pharmaceutical Sciences|May 1, 2017
Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine CandidateWen-Hsiang Chen, Shivali M Chag, Mohan V Poongavanam, et al.Eclinicalmedicine|March 28, 2024
The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling studySarah M Bartsch, Kelly J O'Shea, Danielle C John, et al.Biorxiv : the Preprint Server for Biology|January 16, 2026
Develop a durable, memory-driven, CspZ-targeting Lyme disease vaccine by rationale adjuvant selectionMiranda McCarty, Sergio A Hernández, Jill Malfetano, et al.Current Research in Immunology|August 3, 2023
Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against <i>Trypanosoma cruzi</i>, characterized by an increased level of polyfunctional CD8<sup>+</sup> T-cellsCristina Poveda, Ana Carolina Leão, Chiara Mancino, et al.Nature Communications|April 6, 2025
Mechanistic insights into the structure-based design of a CspZ-targeting Lyme disease vaccineKalvis Brangulis, Jill Malfetano, Ashley L Marcinkiewicz, et al.Human Vaccines & Immunotherapeutics|October 15, 2016
Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas diseaseChristopher A Seid, Kathryn M Jones, Jeroen Pollet, et al.Pageof 10